These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2525359)

  • 1. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis.
    Karnovsky MJ; Wright TC; Castellot JJ; Choay J; Lormeau JC; Petitou M
    Ann N Y Acad Sci; 1989; 556():268-81. PubMed ID: 2525359
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells.
    Nader HB; Pinhal MA; Baú EC; Castro RA; Medeiros GF; Chavante SF; Leite EL; Trindade ES; Shinjo SK; Rocha HA; Tersariol IL; Mendes A; Dietrich CP
    Braz J Med Biol Res; 2001 Jun; 34(6):699-709. PubMed ID: 11378657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
    Kinsella MG; Irvin C; Reidy MA; Wight TN
    Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
    Saito A
    Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis.
    Chang X; Yamada R; Yamamoto K
    Arthritis Res Ther; 2005; 7(2):R268-73. PubMed ID: 15743473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells.
    Delmolino LM; Castellot JJ
    J Cell Physiol; 1997 Dec; 173(3):371-9. PubMed ID: 9369950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity.
    Sasaki M; Kashima M; Ito T; Watanabe A; Sano M; Kagaya M; Shioya T; Miura M
    Mediators Inflamm; 2000; 9(2):85-91. PubMed ID: 10958381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cell-binding site of angiomodulin (AGM/TAF/Mac25) that interacts with heparan sulfates on cell surface.
    Sato J; Hasegawa S; Akaogi K; Yasumitsu H; Yamada S; Sugahara K; Miyazaki K
    J Cell Biochem; 1999 Nov; 75(2):187-95. PubMed ID: 10502291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfation patterns in heparin and heparan sulfate: effects on the proliferation of bovine pulmonary artery smooth muscle cells.
    Garg HG; Yu L; Hales CA; Toida T; Islam T; Linhardt RJ
    Biochim Biophys Acta; 2003 Nov; 1639(3):225-31. PubMed ID: 14636954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycans and the regulation of allergic inflammation.
    Rose MJ; Page C
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):221-5. PubMed ID: 15446270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminally alkylated heparin. 2. Potent antiproliferative agent for vascular smooth muscle cells.
    Gohda M; Magoshi T; Kato S; Noguchi T; Yasuda S; Nonogi H; Matsuda T
    Biomacromolecules; 2001; 2(4):1178-83. PubMed ID: 11777390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of atherosclerosis: the search for genes acting at the level of the vessel wall.
    Villa-Colinayo V; Shi W; Araujo J; Lusis AJ
    Curr Atheroscler Rep; 2000 Sep; 2(5):380-9. PubMed ID: 11122769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfates from arteries and veins differ in their antithrombin-mediated anticoagulant activity.
    de Mattos DA; Stelling MP; Tovar AM; Mourão PA
    J Thromb Haemost; 2008 Nov; 6(11):1987-90. PubMed ID: 18761723
    [No Abstract]   [Full Text] [Related]  

  • 14. Is atherosclerosis an overreaction of the immune system?
    Seely S
    Int J Cardiol; 1998 Oct; 66(3):323-4. PubMed ID: 9874088
    [No Abstract]   [Full Text] [Related]  

  • 15. Rate of apoptosis in human atherosclerosis.
    Mallat Z; Tedgui A
    Am J Pathol; 1998 Oct; 153(4):1320-1. PubMed ID: 9777965
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of heparin on cell division.
    HEILBRUNN LV; WILSON WL
    Proc Soc Exp Biol Med; 1949 Jan; 70(1):179-82. PubMed ID: 18109760
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms simultaneously regulate smooth muscle proliferation and differentiation.
    Shi N; Chen SY
    J Biomed Res; 2014 Jan; 28(1):40-6. PubMed ID: 24474962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide degradation of heparin and heparan sulphate.
    Vilar RE; Ghael D; Li M; Bhagat DD; Arrigo LM; Cowman MK; Dweck HS; Rosenfeld L
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):473-9. PubMed ID: 9182706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-dependent regulation of elastin gene in cultured chick vascular smooth-muscle cells.
    Wachi H; Seyama Y; Yamashita S; Tajima S
    Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):575-9. PubMed ID: 7626022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex carbohydrates in drug development.
    Schnaar RL
    Adv Pharmacol; 1992; 23():35-84. PubMed ID: 1540539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.